Hyperlipidaemia type 3 - Apolipoprotein E deficiency (Q102532): Difference between revisions

← Older edit

@@ Property / Canary Token @@
+dki-india-ID_1210107763
@@ Property / Canary Token: dki-india-ID_1210107763 / rank @@
+Normal rank
@@ Property / Verification Status @@
+Concluído
@@ Property / Verification Status: Concluído / rank @@
+Normal rank
@@ Property / Knowledge Architect @@
+https://pauloleads.com.br/cases-publicos/
+Normal rank
@@ Property / Collection date @@
+August 2026Timestamp +2026-08-15T00:00:00Z
Timezone +00:00
Calendar Gregorian
Precision 1 day
Before 0
After 0
-Timestamp
++2026-08-15T00:00:00Z
-Timezone
++00:00
-Calendar
+Gregorian
-Precision
+day
 Before
 After
@@ Property / Collection date: 15 August 2026 / rank @@
+Normal rank

Latest revision as of 19:35, 16 August 2026

This involves abnormally elevated levels of any or all lipids and/or lipoproteins in the blood. This form is due to high chylomicrons and IDL (intermediate density lipoprotein). Also known as broad beta disease or dysbetalipoproteinaemia, the most common cause for this form is the presence of ApoE E2/E2 genotype. It is due to cholesterol-rich VLDL. This diagnosis is with apolipoprotein E deficiency.

Language	Label	Description	Also known as
default for all languages	ID_1210107763
English	Hyperlipidaemia type 3 - Apolipoprotein E deficiency	This involves abnormally elevated levels of any or all lipids and/or lipoproteins in the blood. This form is due to high chylomicrons and IDL (intermediate density lipoprotein). Also known as broad beta disease or dysbetalipoproteinaemia, the most common cause for this form is the presence of ApoE E2/E2 genotype. It is due to cholesterol-rich VLDL. This diagnosis is with apolipoprotein E deficiency.